NCT05800249View on ClinicalTrials.gov

PE0116 Injection in Treatment of Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

June 2, 2023

Study Completion Date

June 16, 2023

Conditions

Locally Advanced/Metastatic Solid Tumors

Interventions

DRUG

PE0116

This is a Phase I Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics and Preliminary Antitumor Activity of PE0116 Injection in Treatment of Patients with Advanced Solid Tumor

Trial Locations (1)

Unknown

复旦大学附属中山医院, Shanghai

All Listed Sponsors

lead

Shanghai HyaMab Biotech Co.,Ltd.

INDUSTRY

NCT05800249 - PE0116 Injection in Treatment of Patients With Advanced Solid Tumours | Biotech Hunter | Biotech Hunter